Beckman Coulter to acquire Diagnostic Systems Laboratories

By Jennifer Chiou

New York, Oct. 7 - Beckman Coulter, Inc. announced it will acquire Diagnostic Systems Laboratories Corp.

The acquisition is expected to close in mid-October.

"Diagnostic Systems is a mature organization with significant scientific and clinical collaboration skills. Together we aim to quickly broaden our immunoassay menu and strategically advance our already successful immunoassay franchise," group vice president of Beckman Coulter's immunoassay business Michael Whelan said in a news release.

Diagnostic Systems markets three reproductive endocrinology tests, including Inhibin A and B and anti-Mullerian hormone. It also holds exclusive rights to PAPP-A, a marker being evaluated for cardiovascular risk assessment.

Diagnostic Systems had 2004 sales of $34 million.

Terms of the acquisition were not disclosed.

Based in Fullerton, Calif., Beckman Coulter manufactures biomedical testing instrument systems, tests and supplies.

Diagnostic Systems is a Webster, Texas, provider of specialty immunoassays.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.